[1]
“Direct-Acting-Antivirals Anti-hepatitis C Virus in Renal Transplant Patients: Relevance of Pharmacologic Interaction”, jrenhep, vol. 4, no. 2, pp. 29–33, Aug. 2020, doi: 10.15586/jrenhep.v4i2.79.